![](/img/cover-not-exists.png)
Phase (Ph) I/Ib trial of fruquintinib (fru) in patients (pts) with advanced solid tumors: Preliminary results of the dose expansion (exp) cohort in refractory metastatic colorectal cancer (mCRC)
Dasari, N.A., Wang-Gillam, A., Hubbard, J.M., Fernandez, A., Nanda, S., Kania, M., Schelman, W.R., Bekaii-Saab, T.S.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.569
Date:
September, 2020
File:
PDF, 98 KB
2020